This map shows the geographic impact of A. M. Testi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. M. Testi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. M. Testi more than expected).
This network shows the impact of papers produced by A. M. Testi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. M. Testi. The network helps show where A. M. Testi may publish in the future.
Co-authorship network of co-authors of A. M. Testi
This figure shows the co-authorship network connecting the top 25 collaborators of A. M. Testi.
A scholar is included among the top collaborators of A. M. Testi based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with A. M. Testi. A. M. Testi is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Avvisati, Giuseppe, Maria Concetta Petti, Francesco Lo‐Coco, et al.. (2003). The Italian Way of Treating Acute Promyelocytic Leukemia (APL), Final Act. 487–487.2 indexed citations
Testi, A. M., Maria Luisa Moleti, Fiorina Giona, et al.. (1998). A single high dose of idarubicin combined with high-dose ABA-C (MSKCC ALL-3 protocol) in adult and pediatric patients with acute lymphoblastic leukemia. Experience at the University La Sapienza of Rome.. PubMed. 82(5 Suppl). 19–22.8 indexed citations
7.
Iori, A. P., Cesare Guglielmi, Andrea Mengarelli, et al.. (1998). Umbilical cord blood (UCB) transplant from unrelated mismatched donor in patients with high risk (HR) leukemia.. PubMed. 22 Suppl 1. S75–S75.1 indexed citations
Aricò, Maurizio, Valentino Conter, M. Valsecchi, et al.. (1997). Treatment intensification with repeated BFM-protocol II may prevent early relapse in very high risk all AIEOP-ALL 9503 study. 2. 23615.1 indexed citations
10.
Dell’Utri, Donatella, Alessandra Picardi, A. M. Testi, et al.. (1996). Central venous catheterization in pediatric patients affected by hematological malignancies.. PubMed. 80(5). 448–50.7 indexed citations
11.
Amadori, Sergio, Alessandra Picardi, Paola Fazi, et al.. (1996). A phase II study of VP-16, intermediate-dose Ara-C and carboplatin (VAC) in advanced acute myelogenous leukemia and blastic chronic myelogenous leukemia.. PubMed. 10(5). 766–8.13 indexed citations
Amadori, Sergio, Fiorina Giona, Maria Luisa Moleti, et al.. (1992). Therapeutic strategies for postremission treatment in childhood acute myeloid leukemia (AML). The AIEOP experience 1987-1991.. PubMed. 6 Suppl 2. 44–7.4 indexed citations
14.
Arcese, William, Sergio Amadori, A. M. Testi, et al.. (1991). Allogeneic vs autologous BMT vs intensive chemotherapy in childhood AnLL during first complete remission: AIEOP experience. AIEOP Cooperative Group.. PubMed. 7 Suppl 3. 71–4.2 indexed citations
Rossi, Giulio, Marina Frontani, Antonio Spadea, et al.. (1990). Immunoglobulin heavy chain and T-cell receptor beta chain gene rearrangements in acute non lymphoid leukemia.. PubMed. 75(2). 125–8.5 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.